Skip to main content
Erschienen in: Alzheimer's Research & Therapy 3/2010

01.06.2010 | Commentary

Increasing incidence of dementia in the oldest old: evidence and implications

verfasst von: Bryan D James, Julie A Schneider

Erschienen in: Alzheimer's Research & Therapy | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

The oldest old are the fastest growing segment of the US population but accurate estimates of the incidence of dementia in this age group have been elusive. Corrada and colleagues present data on the 5-year age-specific rates of dementia incidence in persons 90 years and older from The 90+ Study. Their findings show a continued exponential increase in dementia incidence after age 90 that mirrors the increase observed in persons aged 65 to 90, with a doubling every 5.5 years. This contrasts with previous smaller studies reporting a slowing of the increase in incidence after age 90. If confirmed, the continued increase, rather than a plateau, in the incidence of dementia in the oldest old has implications for proper healthcare planning. Strategies for prevention and treatment will require more information regarding risk factors and the etiopathogenesis of dementia in the oldest old.
Literatur
1.
Zurück zum Zitat US Census Bureau: Current Population Reports, Special Studies, P23-209, 65+ in the United States: 2005. 2005, Washington DC: Government Printing Office US Census Bureau: Current Population Reports, Special Studies, P23-209, 65+ in the United States: 2005. 2005, Washington DC: Government Printing Office
2.
3.
Zurück zum Zitat Gao S, Hendrie HC, Hall KS, Hui S: The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch Gen Psychiatry. 1998, 55: 809-815. 10.1001/archpsyc.55.9.809.CrossRefPubMed Gao S, Hendrie HC, Hall KS, Hui S: The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch Gen Psychiatry. 1998, 55: 809-815. 10.1001/archpsyc.55.9.809.CrossRefPubMed
4.
Zurück zum Zitat Ritchie K, Kildea D: Is senile dementia 'age-related' or 'ageing-related'? Evidence from meta-analysis of dementia prevalence in the oldest old. Lancet. 1995, 346: 931-934. 10.1016/S0140-6736(95)91556-7.CrossRefPubMed Ritchie K, Kildea D: Is senile dementia 'age-related' or 'ageing-related'? Evidence from meta-analysis of dementia prevalence in the oldest old. Lancet. 1995, 346: 931-934. 10.1016/S0140-6736(95)91556-7.CrossRefPubMed
5.
Zurück zum Zitat Corrada MM, Brookmeyer R, Paganini-Hill A, Berlau D, Kawas CH: Dementia incidence continues to increase with age in the oldest old: the 90+ study. Ann Neurol. 2010, 67: 114-121. 10.1002/ana.21915.PubMedCentralCrossRefPubMed Corrada MM, Brookmeyer R, Paganini-Hill A, Berlau D, Kawas CH: Dementia incidence continues to increase with age in the oldest old: the 90+ study. Ann Neurol. 2010, 67: 114-121. 10.1002/ana.21915.PubMedCentralCrossRefPubMed
6.
Zurück zum Zitat Paganini-Hill A, Ross RK, Henderson BE: Prevalence of chronic disease and health practices in a retirement community. J Chronic Dis. 1986, 39: 699-707. 10.1016/0021-9681(86)90153-0.CrossRefPubMed Paganini-Hill A, Ross RK, Henderson BE: Prevalence of chronic disease and health practices in a retirement community. J Chronic Dis. 1986, 39: 699-707. 10.1016/0021-9681(86)90153-0.CrossRefPubMed
7.
Zurück zum Zitat Hagnell O, Ojesjo L, Rorsman B: Incidence of dementia in the Lundby Study. Neuroepidemiology. 1992, 11 (Suppl 1): 61-66. 10.1159/000110981.CrossRefPubMed Hagnell O, Ojesjo L, Rorsman B: Incidence of dementia in the Lundby Study. Neuroepidemiology. 1992, 11 (Suppl 1): 61-66. 10.1159/000110981.CrossRefPubMed
8.
Zurück zum Zitat Fichter MM, Schroppel H, Meller I: Incidence of dementia in a Munich community sample of the oldest old. Eur Arch Psychiatry Clin Neurosci. 1996, 246: 320-328. 10.1007/BF02189026.CrossRefPubMed Fichter MM, Schroppel H, Meller I: Incidence of dementia in a Munich community sample of the oldest old. Eur Arch Psychiatry Clin Neurosci. 1996, 246: 320-328. 10.1007/BF02189026.CrossRefPubMed
9.
Zurück zum Zitat Canadian Study of Health and Aging Working Group: The incidence of dementia in Canada. Neurology. 2000, 55: 66-73.CrossRef Canadian Study of Health and Aging Working Group: The incidence of dementia in Canada. Neurology. 2000, 55: 66-73.CrossRef
10.
Zurück zum Zitat Ruitenberg A, Ott A, van Swieten JC, Hofman A, Breteler MM: Incidence of dementia: does gender make a difference?. Neurobiol Aging. 2001, 22: 575-580. 10.1016/S0197-4580(01)00231-7.CrossRefPubMed Ruitenberg A, Ott A, van Swieten JC, Hofman A, Breteler MM: Incidence of dementia: does gender make a difference?. Neurobiol Aging. 2001, 22: 575-580. 10.1016/S0197-4580(01)00231-7.CrossRefPubMed
11.
Zurück zum Zitat Edland SD, Rocca WA, Petersen RC, Cha RH, Kokmen E: Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn. Arch Neurol. 2002, 59: 1589-1593. 10.1001/archneur.59.10.1589.CrossRefPubMed Edland SD, Rocca WA, Petersen RC, Cha RH, Kokmen E: Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn. Arch Neurol. 2002, 59: 1589-1593. 10.1001/archneur.59.10.1589.CrossRefPubMed
12.
Zurück zum Zitat Miech RA, Breitner JC, Zandi PP, Khachaturian AS, Anthony JC, Mayer L: Incidence of AD may decline in the early 90s for men, later for women: the Cache County study. Neurology. 2002, 58: 209-218.CrossRefPubMed Miech RA, Breitner JC, Zandi PP, Khachaturian AS, Anthony JC, Mayer L: Incidence of AD may decline in the early 90s for men, later for women: the Cache County study. Neurology. 2002, 58: 209-218.CrossRefPubMed
13.
Zurück zum Zitat Hall CB, Verghese J, Sliwinski M, Chen Z, Katz M, Derby C, Lipton RB: Dementia incidence may increase more slowly after age 90: results from the Bronx Aging Study. Neurology. 2005, 65: 882-886. 10.1212/01.wnl.0000176053.98907.3f.CrossRefPubMed Hall CB, Verghese J, Sliwinski M, Chen Z, Katz M, Derby C, Lipton RB: Dementia incidence may increase more slowly after age 90: results from the Bronx Aging Study. Neurology. 2005, 65: 882-886. 10.1212/01.wnl.0000176053.98907.3f.CrossRefPubMed
14.
Zurück zum Zitat Sonnen JA, Larson EB, Haneuse S, Woltjer R, Li G, Crane PK, Craft S, Montine TJ: Neuropathology in the adult changes in thought study: a review. J Alzheimers Dis. 2009, 18: 703-711.PubMedCentralPubMed Sonnen JA, Larson EB, Haneuse S, Woltjer R, Li G, Crane PK, Craft S, Montine TJ: Neuropathology in the adult changes in thought study: a review. J Alzheimers Dis. 2009, 18: 703-711.PubMedCentralPubMed
15.
Zurück zum Zitat Brayne C, Richardson K, Matthews FE, Fleming J, Hunter S, Xuereb JH, Paykel E, Mukaetova-Ladinska EB, Huppert FA, O'Sullivan A, Dening T: Neuropathological correlates of dementia in over-80-year-old brain donors from the population-based Cambridge city over-75s cohort (CC75C) study. J Alzheimers Dis. 2009, 18: 645-658.PubMed Brayne C, Richardson K, Matthews FE, Fleming J, Hunter S, Xuereb JH, Paykel E, Mukaetova-Ladinska EB, Huppert FA, O'Sullivan A, Dening T: Neuropathological correlates of dementia in over-80-year-old brain donors from the population-based Cambridge city over-75s cohort (CC75C) study. J Alzheimers Dis. 2009, 18: 645-658.PubMed
16.
Zurück zum Zitat Schneider JA, Arvanitakis Z, Bang W, Bennett DA: Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007, 69: 2197-2204. 10.1212/01.wnl.0000271090.28148.24.CrossRefPubMed Schneider JA, Arvanitakis Z, Bang W, Bennett DA: Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007, 69: 2197-2204. 10.1212/01.wnl.0000271090.28148.24.CrossRefPubMed
17.
Zurück zum Zitat Jellinger KA, Attems J: Prevalence of dementia disorders in the oldest-old: an autopsy study. Acta Neuropathol. 2010, 119: 421-433. 10.1007/s00401-010-0654-5.CrossRefPubMed Jellinger KA, Attems J: Prevalence of dementia disorders in the oldest-old: an autopsy study. Acta Neuropathol. 2010, 119: 421-433. 10.1007/s00401-010-0654-5.CrossRefPubMed
18.
Zurück zum Zitat Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C: Age, neuropathology, and dementia. N Engl J Med. 2009, 360: 2302-2309. 10.1056/NEJMoa0806142.CrossRefPubMed Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C: Age, neuropathology, and dementia. N Engl J Med. 2009, 360: 2302-2309. 10.1056/NEJMoa0806142.CrossRefPubMed
19.
Zurück zum Zitat Drachman DA: If we live long enough, will we all be demented?. Neurology. 1994, 44: 1563-1565.CrossRefPubMed Drachman DA: If we live long enough, will we all be demented?. Neurology. 1994, 44: 1563-1565.CrossRefPubMed
Metadaten
Titel
Increasing incidence of dementia in the oldest old: evidence and implications
verfasst von
Bryan D James
Julie A Schneider
Publikationsdatum
01.06.2010
Verlag
BioMed Central
Erschienen in
Alzheimer's Research & Therapy / Ausgabe 3/2010
Elektronische ISSN: 1758-9193
DOI
https://doi.org/10.1186/alzrt32

Weitere Artikel der Ausgabe 3/2010

Alzheimer's Research & Therapy 3/2010 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.